Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Kramer

Showing results (251-260 of 388) with videos related to

Pageof 39
Sort By:
International Journal of Cardiology|August 12, 2022
The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysisChristos A Papanastasiou, Maria-Anna Bazmpani, Damianos G Kokkinidis, et al.
Journal of the American College of Cardiology|September 3, 2025
Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification-Based AnalysisMilton Packer, Michael R Zile, Christopher M Kramer, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2004
Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodelingChristina M Bove, Zequan Yang, Wesley D Gilson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 9, 2009
Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonistRajan A G Patel, David K Glover, Alexis Broisat, et al.
Magnetic Resonance in Medicine|June 2, 2011
T₂ -weighted MRI of post-infarct myocardial edema in miceRonald J Beyers, R Scott Smith, Yaqin Xu, et al.
Journal of the American College of Cardiology|November 20, 2024
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR SubstudyChristopher M Kramer, Barry A Borlaug, Michael R Zile, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|July 2, 2010
The association of lesion eccentricity with plaque morphology and components in the superficial femoral artery: a high-spatial-resolution, multi-contrast weighted CMR studyFeiyu Li, Mary McGrae McDermott, Debiao Li, et al.
JACC. Cardiovascular Imaging|April 18, 2021
Functional and Economic Impact of INOCA and Influence of Coronary Microvascular DysfunctionChristopher L Schumann, Roshin C Mathew, John-Henry L Dean, et al.
Journal of Cardiovascular Pharmacology|December 14, 2011
A nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in miceAlexander B Jehle, Yaqin Xu, Joseph M Dimaria, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 11, 2005
The angiotensin II type 2 receptor and improved adjacent region function post-MIChristina M Bove, Wesley D Gilson, Christopher D Scott, et al.
Pageof 39

Showing results (251-260 of 388) with videos related to

Sort By:
Pageof 39
International Journal of Cardiology|August 12, 2022
The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysisChristos A Papanastasiou, Maria-Anna Bazmpani, Damianos G Kokkinidis, et al.
Journal of the American College of Cardiology|September 3, 2025
Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification-Based AnalysisMilton Packer, Michael R Zile, Christopher M Kramer, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2004
Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodelingChristina M Bove, Zequan Yang, Wesley D Gilson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 9, 2009
Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonistRajan A G Patel, David K Glover, Alexis Broisat, et al.
Magnetic Resonance in Medicine|June 2, 2011
T₂ -weighted MRI of post-infarct myocardial edema in miceRonald J Beyers, R Scott Smith, Yaqin Xu, et al.
Journal of the American College of Cardiology|November 20, 2024
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR SubstudyChristopher M Kramer, Barry A Borlaug, Michael R Zile, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|July 2, 2010
The association of lesion eccentricity with plaque morphology and components in the superficial femoral artery: a high-spatial-resolution, multi-contrast weighted CMR studyFeiyu Li, Mary McGrae McDermott, Debiao Li, et al.
JACC. Cardiovascular Imaging|April 18, 2021
Functional and Economic Impact of INOCA and Influence of Coronary Microvascular DysfunctionChristopher L Schumann, Roshin C Mathew, John-Henry L Dean, et al.
Journal of Cardiovascular Pharmacology|December 14, 2011
A nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in miceAlexander B Jehle, Yaqin Xu, Joseph M Dimaria, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 11, 2005
The angiotensin II type 2 receptor and improved adjacent region function post-MIChristina M Bove, Wesley D Gilson, Christopher D Scott, et al.
Pageof 39